Brief: Silo Pharma Announces Filing Of Patent For Treatment Of Fibromyalgia
27/03/2023 14:09
March 27 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA ANNOUNCES FILING OF PATENT FOR TREATMENT OF
FIBROMYALGIA
* SILO PHARMA INC - ACTION SUPPORTS PLANNED IND PACKAGE
SUBMISSION
TO FDA FOR SP-26
Source text for Eikon: ID:nGNX8nZJqV
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement